NOVAVAX INC — Director's Dealing 2021

Jun 29, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2021-06-25

Reporting Person: King Rachel K. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-25	Common Stock	M	6900	—	Acquired	9700	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-25	Restricted Stock Units	$	M	6900	Disposed		Common Stock (6900)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1100	Indirect
Common Stock	1100	Indirect

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

F2: Represents shares attributable to the Reporting Person as indirect holdings held in a trust for the benefit of the Reporting Person's child.

F3: Represents shares attributable to the Reporting Person as indirect holdings held in a trust for the benefit of the Reporting Person's child.

F4: One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 25, 2020 grant date subject to continued service on the Company's Board of Directors through the vesting date.